维普中文期刊产品整合服务
36篇 您的检索式:作者名="Rolin B"
    题名 作者 年代 出处 被引量
1The novel, xanthinebased, DPP IV inhibitor NN7201 and LAF237 of the long-acting GLP- 1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats显示文摘Rolin B 2004Diabetes2004,50,7:1
2The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice显示文摘Rolin B Larsen MO Gotfredsen CF 2002Am J Physiol Endocrinol Metab2002,283,4:1
3The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice 显示文摘ROLIN B LARSEN M O GOTFREDSEN C F 2002Am J Physiol EndocrinolMetab2002,283,2:1
4Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Cottingen Minipigs in vivo显示文摘Larsen MO Rolin B Stuffs J 2006Am J Physiol Endocrinol Metab2006,290,:1
5Use of the Gttingen Minipigs as a Model of Diabetes, with Special Focus on Type 1 Diabetes Research 显示文摘Larsen M O Rolin B 2004ILAR Journal2004,45,3:1
6The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice 显示文摘ROLIN B LARSEN M O GOTFREDSEN C F 2002Am J Physiol Endocrinol Metab2002,283,4:1
7Parameters of glucose and lipid metabolism in the male gottingen minipig: influence of age, body weight, and breeding family显示文摘Larsen MO Rolin B Wilken M 2001Comp Med2001,51,5:1
8High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig:results from a pilot study显示文摘Larsen M O Rolin B Wilken M 2002Ann N Y Acad Sci2002,967,:1
9The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases B-cell mass in diabetic mice显示文摘Rolin B Larsen MO Gofredsen CF et el 2002Am J PhysiolEndoerinol Metab2002,283,4:1
10Use of the Gottingen minipig as a model of diabetes,with special focus on type1diabetes research显示文摘Larsen M O Rolin B 2004ILAR Journal2004,45,3:1
11Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing mefformin sulfonylurea treatment in patients with type 2 diabetes显示文摘Fineman MS Rolin B Caumo A 2003Diabetes Care2003,26,9:1
12The novel,xanthinebased,DPP Ⅳ inhibitor NN7201 and LAF237 of the long-acting GLP-1 derivative NN2211 induces lastihg and reversible weight loss in both normal and obese rats显示文摘Rolin B 2004Diabetes2004,50,7:1
13Reduction of beta cell mass:partial insulin secretary compensation from the residual beta cell population in the nicotinamide-streptozotocin G(o)ttingen minipig after oral glucose in vivo and in the perfused pancreas显示文摘 ROLIN B GOTFREDSEN C F 2004Diabetologia2004,47,:1
14The long-acting GLP-1 derivative NN2211 ameliorates glycemia and inerease beta-cell Ⅱ lass in diabetic mice显示文摘Rolin B Larsen MO Goffredsen CF 2002Am J Physiol Endocrinol Metab2002,283,:1
15The long-acting GLP-1 derivative NN2211 ameliorates glycemiaand increases β-cell mass in diabetic mice显示文摘Rolin B 2002Metab2002,283,6:1
16The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cel mass in diabetic mice显示文摘Rolin B Larsen MO Gotfredsen CF 0,,04:1
17High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Guttingen minipig: results from a pilot study显示文摘Larsen MO Rolin B Wilken M 2002Ann N Y Acad Sci2002,967,:1
18Measurements of insulin secretory capacity and glucose tolerence to predict pancreatic β cell mass in vivo in the nicotinamide/streptozotocin Gottingen minipig,a model of moderate insulin deficiencyand diabetes显示文摘Larsen MO Rolin B Wiwilken M 0,,:1
19Synthesis and pharma- cological evaluation of a new targeted drug carrier system: beta cyclodextrin coupled to oxytocin显示文摘Bertolla C Rolin S Evrard B 2008Bioorg Med Chem Lett2008,18,18:1
20Synthesis and pharmacologi-cal evaluation of a new targeted drug carrier system beta-cyclodex-trin coupled to oxytocin显示文摘Bertolla C Rolin S P Evrard B 2008Bioorg Med Chem Lett2008,18,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费